Massive markup on high-cost drugs: Raids to continue, Karnataka writes to Centre
The next phase of raids will focus on antiretroviral drugs, higher-generation and critical antibiotics, medical devices, and hospital consumables with significant financial implications for patients
The Karnataka government has expressed concern over the significant markup on high-cost drugs, cancer medications, antibiotics, and hospital consumables, which is causing a disparity between the institutional landing costs and the Maximum Retail Prices (MRP) charged to patients. Recent investigations by the Karnataka Food Safety and Drug Administration (FSDA) have uncovered extreme pricing anomalies in 253 drugs, with markups ranging from 10 times to over 52 times the actual procurement cost.
The Karnataka government has requested the Union Ministry of Health and Family Welfare and the National Pharmaceutical Pricing Authority (NPPA) to take action, including mandating transparency in institutional pricing, expanding the list of drugs under price control, and regulating trade margins on essential high-value medicines.
Brief written by urgent.news from The Hindu Health's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
